Capitolis Advisors’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
Capitolis Advisors's OGN Position: Q2 2022 in Review
Capitolis Advisors sold out of Organon & Co (OGN) in Q2 2022, closing a stake of 311 shares — an estimated $11K sold.
Capitolis Advisors first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $678K in Q2 2021. 852 funds tracked by Wall St. Rank hold OGN as of Q2 2022.
- Capitolis Advisors reported no remaining Organon & Co position as of Q2 2022 after selling out during the quarter.
- Capitolis Advisors sold 311 Organon & Co shares in Q2 2022, an estimated $11K.
- Capitolis Advisors first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
- Capitolis Advisors's Organon & Co position peaked at $678K in Q2 2021.
- 852 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.
Based on Capitolis Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.